Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not

G Spizz1, J S Hu, E N Olson

  • 1Department of Biochemistry and Molecular Biology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston 77030.

Developmental Biology
|October 1, 1987
PubMed

Insights

Persistent c-myc expression is not required for growth factor inhibition of skeletal muscle differentiation. Growth factors like FGF and TGF-beta can suppress myogenesis, even when c-myc levels remain low.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Skeletal muscle differentiation involves MCK mRNA accumulation.
  • Myogenesis can be inhibited by serum, FGF, and TGF-beta.
  • The role of c-myc in this inhibition is not fully understood.

Purpose of the Study:

  • To investigate the involvement of c-myc in growth factor-dependent inhibition of myogenesis.
  • To examine the relationship between c-myc expression and myogenic differentiation in BC3H1 cells.

Main Methods:

  • Utilized the BC3H1 nonfusing myogenic cell line.
  • Manipulated serum concentration and exposure to FGF and TGF-beta.
  • Monitored c-myc and MCK mRNA expression levels.

Main Results:

  • Withdrawal from the cell cycle led to decreased c-myc mRNA and increased MCK mRNA.
  • TGF-beta suppressed MCK mRNA despite c-myc decline.
  • FGF and TGF-beta induced transient c-myc expression but inhibited muscle-specific gene products.

Conclusions:

  • Persistent c-myc expression is not essential for growth factor-mediated inhibition of myogenic differentiation.
  • Growth factors can inhibit myogenesis independently of sustained c-myc activity.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...